For: | Mishra R, Dhawan P, Srivastava AS, Singh AB. Inflammatory bowel disease: Therapeutic limitations and prospective of the stem cell therapy. World J Stem Cells 2020; 12(10): 1050-1066 [PMID: 33178391 DOI: 10.4252/wjsc.v12.i10.1050] |
---|---|
URL: | https://www.wjgnet.com/2150-5349/full/v12/i10/1050.htm |
Number | Citing Articles |
1 |
Cheng-mei Tian, Mei-feng Yang, Hao-ming Xu, Min-zheng Zhu, Ning-Ning Yue, Yuan Zhang, Rui-yue Shi, Jun Yao, Li-sheng Wang, Yu-jie Liang, De-feng Li. Stem cell-derived intestinal organoids: a novel modality for IBD. Cell Death Discovery 2023; 9(1) doi: 10.1038/s41420-023-01556-1
|
2 |
Mahdi Masrour, Aysan Moeinafshar, Nima Rezaei. Comprehensive Hematology and Stem Cell Research. 2024; : 1 doi: 10.1016/B978-0-443-15717-2.00059-7
|
3 |
Lie Zheng, Sheng-Lei Duan, Xin-Li Wen, Yan-Cheng Dai. Molecular regulation after mucosal injury and regeneration in ulcerative colitis. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.996057
|
4 |
Jialing Liu, Xingqiang Lai, Yingying Bao, Wenfeng Xie, Zhishan Li, Jieying Chen, Gang Li, Tao Wang, Weijun Huang, Yuanchen Ma, Jiahao Shi, Erming Zhao, Andy Peng Xiang, Qiuli Liu, Xiaoyong Chen. Intraperitoneally Delivered Mesenchymal Stem Cells Alleviate Experimental Colitis Through THBS1-Mediated Induction of IL-10-Competent Regulatory B Cells. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.853894
|
5 |
Wanda Lattanzi, Cristian Ripoli, Viviana Greco, Marta Barba, Federica Iavarone, Angelo Minucci, Andrea Urbani, Claudio Grassi, Ornella Parolini. Basic and Preclinical Research for Personalized Medicine. Journal of Personalized Medicine 2021; 11(5): 354 doi: 10.3390/jpm11050354
|
6 |
Paolo Corbetta, Elena Lonati, Stefania Pagliari, Mario Mauri, Emanuela Cazzaniga, Laura Botto, Luca Campone, Paola Palestini, Alessandra Bulbarelli. Flavonoids-Enriched Vegetal Extract Prevents the Activation of NFκB Downstream Mechanisms in a Bowel Disease In Vitro Model. International Journal of Molecular Sciences 2024; 25(14): 7869 doi: 10.3390/ijms25147869
|
7 |
Cheng-Mei Tian, Yuan Zhang, Mei-Feng Yang, Hao-Ming Xu, Min-Zheng Zhu, Jun Yao, Li-Sheng Wang, Yu-Jie Liang, De-Feng Li. Stem Cell Therapy in Inflammatory Bowel Disease: A Review of Achievements and Challenges. Journal of Inflammation Research 2023; : 2089 doi: 10.2147/JIR.S400447
|
8 |
Xu Feng, Ye Xiao, Jian He, Mi Yang, Qi Guo, Tian Su, Yan Huang, Jun Yi, Chang-Jun Li, Xiang-Hang Luo, Xiao-Wei Liu, Hai-Yan Zhou. Long noncoding RNA Gm31629 protects against mucosal damage in experimental colitis via YB-1/E2F pathway. JCI Insight 2022; 7(6) doi: 10.1172/jci.insight.150091
|
9 |
Valentina Arrè, Rosanna Scialpi, Matteo Centonze, Gianluigi Giannelli, Maria Principia Scavo, Roberto Negro. The ‘speck’-tacular oversight of the NLRP3-pyroptosis pathway on gastrointestinal inflammatory diseases and tumorigenesis. Journal of Biomedical Science 2023; 30(1) doi: 10.1186/s12929-023-00983-7
|
10 |
Daisuke Hisamatsu, Akimi Ikeba, Taku Yamato, Yo Mabuchi, Mamoru Watanabe, Chihiro Akazawa. Optimization of transplantation methods using isolated mesenchymal stem/stromal cells: clinical trials of inflammatory bowel diseases as an example. Inflammation and Regeneration 2024; 44(1) doi: 10.1186/s41232-024-00350-5
|
11 |
Lin Xu, Jiaqi Zhang, Yifan Wang, Zedan Zhang, Fengyun Wang, Xudong Tang. Uncovering the mechanism of Ge-Gen-Qin-Lian decoction for treating ulcerative colitis based on network pharmacology and molecular docking verification. Bioscience Reports 2021; 41(2) doi: 10.1042/BSR20203565
|
12 |
Eun Mi Song, Yang Hee Joo, A. Reum Choe, Yehyun Park, Chung Hyun Tae, Ji Teak Hong, Chang Mo Moon, Seong-Eun Kim, Hye-Kyung Jung, Ki-Nam Shim, Kyung-Ah Cho, Inho Jo, Sung-Ae Jung. Three-dimensional culture method enhances the therapeutic efficacies of tonsil-derived mesenchymal stem cells in murine chronic colitis model. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-98711-4
|
13 |
Zhengping Che, Ziyu Ye, Xueying Zhang, Bihua Lin, Weiqing Yang, Yanfang Liang, Jincheng Zeng. Mesenchymal stem/stromal cells in the pathogenesis and regenerative therapy of inflammatory bowel diseases. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.952071
|
14 |
Jeremy Y. Ng, Henry Liu, Michelle Chenghuazou Wang. Complementary and alternative medicine mention and recommendations in inflammatory bowel disease guidelines: systematic review and assessment using AGREE II. BMC Complementary Medicine and Therapies 2023; 23(1) doi: 10.1186/s12906-023-04062-0
|
15 |
Vishal Khatri, Ramaswamy Kalyanasundaram. Therapeutic implications of inflammasome in inflammatory bowel disease. The FASEB Journal 2021; 35(5) doi: 10.1096/fj.202002622R
|
16 |
Jisu Kim, Shuya Zhang, Ying Zhu, Ruirui Wang, Jianxin Wang. Amelioration of colitis progression by ginseng-derived exosome-like nanoparticles through suppression of inflammatory cytokines. Journal of Ginseng Research 2023; 47(5): 627 doi: 10.1016/j.jgr.2023.01.004
|
17 |
Xu-Feng Mao, Xi-Qian Zhang, Zhe-Yu Yao, Hai-Jiao Mao. Advances in mesenchymal stem cells therapy for tendinopathies. Chinese Journal of Traumatology 2024; 27(1): 11 doi: 10.1016/j.cjtee.2023.11.002
|
18 |
Maitham A. Khajah, Sanaa Hawai, Ahmad Barakat, Aisha Albaloushi, Maha Alkharji, Willias Masocha. Minocycline synergizes with corticosteroids in reducing colitis severity in mice via the modulation of pro-inflammatory molecules. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1252174
|
19 |
Xinyao Meng, Jun Xiao, Jing Wang, Minxian Sun, Xuyong Chen, Luyao Wu, Ke Chen, Zejian Li, ChenZhao Feng, Didi Zhuansun, Jixin Yang, Xiaojuan Wu, Donghai Yu, Wei Li, Yonghua Niu, Ying He, Mingfa Wei, Feng Chen, Bo Xiong, Jiexiong Feng, Tianqi Zhu. Mesenchymal Stem Cells Attenuates Hirschsprung diseases - Associated Enterocolitis by Reducing M1 Macrophages Infiltration via COX-2 Dependent Mechanism. Journal of Pediatric Surgery 2024; 59(8): 1498 doi: 10.1016/j.jpedsurg.2024.02.033
|
20 |
Marzena Mazur, Jakub Włodarczyk, Mikołaj Świerczyński, Radzisław Kordek, Marcin M. Grzybowski, Jacek Olczak, Jakub Fichna. The Anti-Inflammatory Effect of Acidic Mammalian Chitinase Inhibitor OAT-177 in DSS-Induced Mouse Model of Colitis. International Journal of Molecular Sciences 2022; 23(4): 2159 doi: 10.3390/ijms23042159
|
21 |
Zhaobei Cai, Shu Wang, Jiannan Li. Treatment of Inflammatory Bowel Disease: A Comprehensive Review. Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.765474
|
22 |
Biljana Stankovic, Nikola Kotur, Gordana Nikcevic, Vladimir Gasic, Branka Zukic, Sonja Pavlovic. Machine Learning Modeling from Omics Data as Prospective Tool for Improvement of Inflammatory Bowel Disease Diagnosis and Clinical Classifications. Genes 2021; 12(9): 1438 doi: 10.3390/genes12091438
|
23 |
Bing Liang, Yanhong Wang, Jiazhen Xu, Yingchun Shao, Dongming Xing. Unlocking the potential of targeting histone-modifying enzymes for treating IBD and CRC. Clinical Epigenetics 2023; 15(1) doi: 10.1186/s13148-023-01562-1
|
24 |
Shulin Wei, Mingxing Li, Qin Wang, Yueshui Zhao, Fukuan Du, Yu Chen, Shuai Deng, Jing Shen, Ke Wu, Jiayue Yang, Yuhong Sun, Li Gu, Xiaobing Li, Wanping Li, Meijuan Chen, Xiao Ling, Lei Yu, Zhangang Xiao, Lishu Dong, Xu Wu. Mesenchymal Stromal Cells: New Generation Treatment of Inflammatory Bowel Disease. Journal of Inflammation Research 2024; : 3307 doi: 10.2147/JIR.S458103
|